Do you think RC220, will have a material impact on recruitment for any upcoming Sheba trials?
Being administered via IV, will that assist late stage patients who are presenting liver issues?
ASH2023 - Sheba 2.0, page-140
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.50 |
Change
0.050(3.45%) |
Mkt cap ! $248.8M | |||
| Open | High | Low | Value | Volume |
| $1.47 | $1.50 | $1.47 | $85.04K | 57.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6000 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 2408 | 1 |
View Market Depth
| Last trade - 11.57am 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.50 |
Change
0.050 ( 2.05 %) |
||||
| Open | High | Low | Volume | ||
| $1.49 | $1.50 | $1.47 | 4207 | ||
| Last updated 11.57am 27/05/2024 ? | |||||
| RAC (ASX) Chart |